A mixed blessing for liver transplantation patients — Rapamycin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A mixed blessing for liver transplantation patients — Rapamycin

Published:2023-02 Issue:1 Volume:22 Page:14-21
ISSN:1499-3872
Container-title:Hepatobiliary & Pancreatic Diseases International
language:en
Short-container-title:Hepatobiliary & Pancreatic Diseases International

Author:

Fan Guang-Han,Zhang Chen-Zhi,Gao Feng-Qiang,Wei Xu-Yong,Ling Sun-Bin,Wang Kai,Wang Jian-Guo,Zheng Shu-Sen,Nikfarjam Mehrdad,Xu Xiao

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference115 articles.

1. Hepatocellular carcinoma

2. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

3. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

4. The management of post-transplantation recurrence of hepatocellular carcinoma;Rajendran;Clin Mol Hepatol,2022

5. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation;Burra;J Hepatol,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin, aspirin and metformin use and risk of hepatocellular carcinoma related outcomes following liver transplantation: A retrospective study;World Journal of Transplantation;2024-09-18

2. Idiopathic Multicentric Castleman Disease With Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Insufficiency, and Organomegaly (TAFRO) Syndrome in a Liver Transplant Recipient;ACG Case Reports Journal;2024-07-27

3. Salidroside ameliorates acute liver transplantation rejection in rats by inhibiting neutrophil extracellular trap formation;Acta Biochimica et Biophysica Sinica;2024-05-01

4. Pharmacological effects of mTORC1/C2 inhibitor in a preclinical model of NASH progression;Biomedicine & Pharmacotherapy;2023-11

5. Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma;Frontiers in Immunology;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3